TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: decrements in health status
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: decrements in mood
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: objective memory performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: subjective memory subtest results
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: incidence of hematuria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: discomfort related to catheter placement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of M. avium complex infection
Endpoint domain: Adverse events/effects
Primary endpoint: Prediction of IHA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Likelihood of women's reports of disrespectful treatment during childbirth
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: US prostate cancer mortality reduction
Endpoint domain: Mortality/survival
Primary endpoint: 24-hour RBC recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: median life span (T(50)) of circulating test RBCs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: area under the curve of surviving RBCs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Delivery of individual emergency plans
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Unscheduled emergency visits
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Neutrophil/lymphocyte ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clonal expansion of CD8+ MBP-reactive T cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cytokine mRNA quantification of mononuclear cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Interobserver variability in morphometric measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduce the incidences of Adverse Childhood Experiences (ACEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Diagnose and treat clients with a dual diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Mental health outcomes
Primary endpoint: Educate clients, their families, the public and allied health care professionals on all aspects of OUD
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Resolution of Rome III criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SIBO negativity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postexercise energy intake variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Viral load rebound
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Emotional distress experienced by volunteers
Endpoint domain: Adverse events/effects
Primary endpoint: Rib fractures in patients
Endpoint domain: Adverse events/effects
Primary endpoint: Inappropriate shocks or failures to shock
Endpoint domain: Adverse events/effects
Primary endpoint: Classroom behaviour
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Student satisfaction with the program
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Formation of hard tissue bridge (HTB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Excessive sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative fever prevalence
Endpoint domain: Adverse events/effects
Primary endpoint: Time to endoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximal stimulation of Muscle Protein Synthesis (MPS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amino Acid Pool Size (APS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Leucine oxidation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Freedom from rejection
Endpoint domain: Mortality/survival
Primary endpoint: Condom use attitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Behavioral skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: school-day sedentary time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: dietary knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: mean monophasic DFT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Regurgitant volume index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Forward cardiac output index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Median urine FTC concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median urine TFV concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to treatment initiation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Health systems delay
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Direct out-of-pocket medical costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Inversion strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Eversion strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: 24-hour and daytime systolic BP (SBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: MRC sum score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fecal and urinary excretion of unchanged topotecan
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of overall post-operative complications
Endpoint domain: Adverse events/effects
Primary endpoint: area under the doxylamine concentration‐time curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: KSS change from baseline
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Incidence of headache
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to reversal of TOF ratios to 1.0
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hard tissue alteration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HCV RNA negative or >/= 2 log reduction of HCV RNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Analgetic efficacy (pain, stress and well-being)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ability to proceed with normal activities
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Side effects of Tramadol
Endpoint domain: Adverse events/effects
Primary endpoint: time to any mood event
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: preventing any mood relapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: preventing mania
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dexamethasone AUC0‐12h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall reach of interventions
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Estimated median radiation dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in log10 total bacterial count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Symptom response to nutrient challenge
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Postoperative wall motion score index improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Coronary lesion progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Risk of PH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knee Joint Pain Score (KJPS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity for CIN2+
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: uEPX levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: decreased pain level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: comprehension of information
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Clinical or subclinical anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Clinical or subclinical depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Heartburn incidence
Endpoint domain: Adverse events/effects
Primary endpoint: 24-hour proteinuria levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Mean maximum K value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean CDVA improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of change of CIWA-Ar scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of change for systolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of patients free of withdrawal symptoms within 72 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of severe deformational plagiocephaly
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival free of new vascular events in the treated limb
Endpoint domain: Mortality/survival
Primary endpoint: Global response rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Analog Pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alleviation of upper airway symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction with initial CPAP treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Willingness to use CPAP
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction in levels of proinflammatory mediators (IL-6 and TNF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reduction in expression of genes encoding proinflammatory mediators
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: bleeding rate
Endpoint domain: Adverse events/effects
Primary endpoint: urinary retention rate
Endpoint domain: Adverse events/effects
Primary endpoint: PC20H levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Serum sDPP‐4 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inhibition of neointimal hyperplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Mean initial response time (days)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ALT and AST levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Steatosis and cellular ballooning improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: level of aphthous ulcer activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Normalization of mediotemporal and prefrontal dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mediotemporal‐striatal functional connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Symptom reduction in psychosis patients
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: improvement in peak flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: less use of rescue medication
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: improvement in asthma symptoms
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Reduction of weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Creatinine clearance after 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: End-stage renal failure (hemodialysis)
Endpoint domain: Mortality/survival
Primary endpoint: Prolonged excretion time of radiopharmaceutical
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Prolonged extrahepatic bile flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: SBESS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: thoracic Cobb angle improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: body asymmetry improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: trunk deformity improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adjusted ANC score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of women with ≥6 ANC visits
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of syphilis testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Rates of HIV testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: cause-specific survival rates
Endpoint domain: Mortality/survival
Primary endpoint: incidence of late complications
Endpoint domain: Adverse events/effects
Primary endpoint: Steatorrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Fecal weight losses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Nitrogen losses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: HBV-DNA load
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AFP level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in post‐traumatic stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Clinical acceptability of the safety system
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in risk of misconnection between conventional syringe and safety spinal needle
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in risk of misconnection between safety syringe and i.v. Luer device
Endpoint domain: Adverse events/effects
Primary endpoint: Submucosal eosinophil counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: pre-pPCI ST-segment resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Neonatal morbidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neonatal outcomes
Primary endpoint: nadir nocturnal plasma glucose concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean time to haemostasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Percentage of patients successfully treated
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: minimum concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in DSI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in Voice Handicap Index
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Self-perceived vocal quality
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: decreased change from baseline viral load
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: viral shedding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in Hb levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in ZPP/H ratios
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Likelihood of vaginal births after cesareans
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: major trophic sequelae
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average cause-specific mortality fraction accuracy
Endpoint domain: Mortality/survival
Primary endpoint: Overall general health status
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: mean COHbt1/2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative AP and CC diameters and ACSA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PONV incidence and severity
Endpoint domain: Adverse events/effects
Primary endpoint: vibrato rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: phonemic fluency score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: backward digit span score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: composite cognitive score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Aberrant beta-catenin expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Sinus rhythm persistence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: frequency of relapsing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: corticosteroid toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Resistance index and pulsatility index values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: average time of manipulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of successfully placed cubes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average tremor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Occurrence of major adverse cardiac events (MACE)
Endpoint domain: Mortality/survival
Primary endpoint: Increase of plasma creatine kinase (CK-MB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Levels of troponin-I (cTnI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Clinical symptoms of medically unexplained pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean duration of the procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: self‐evaluated measures of pain
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Renal plasma flow (RPF) response to L-NMMA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Duration of vancomycin or linezolid administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total HITS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: IL-1beta gene expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: CRP reduction in IL1(Pos) subjects
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: PaCO2 concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: K+ concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: decrease of urinary protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: improvement of plasma albumin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: remission rate
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: VAS scores for sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall colonic transit (geometric center at 24 h)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Pulmonary aspiration
Endpoint domain: Adverse events/effects
Primary endpoint: Viscosity of fluids
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fluid intake
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Attitude-based questions improvement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing